Logo image of PRAX

PRAXIS PRECISION MEDICINES I (PRAX) Stock Analyst Ratings

NASDAQ:PRAX - Nasdaq - US74006W2070 - Common Stock - Currency: USD

39.7  +2.35 (+6.29%)

After market: 39.7 0 (0%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to PRAX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 101.26. This target is 155.06% above the current price.
PRAX was analyzed by 17 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about PRAX.
In the previous month the buy percentage consensus was at a similar level.
PRAX was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
PRAX Historical Analyst RatingsPRAX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -54 -49 -44 -39 -34 -29 -24 -19 -14 -9 -4 5 10 15

Price Target & Forecast

Price Low Median Mean High 39.7028.2886.70101.26283.50 - -28.77% 118.39% 155.06% 614.11%
PRAX Current Analyst RatingPRAX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-05-07 Chardan Capital Initiate Buy
2025-05-05 Needham Reiterate Buy -> Buy
2025-05-05 Wedbush Maintains Underperform -> Underperform
2025-05-01 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-08 Needham Reiterate Buy -> Buy
2025-03-03 Needham Maintains Buy -> Buy
2025-03-03 Truist Securities Maintains Buy -> Buy
2025-03-03 Baird Maintains Outperform -> Outperform
2025-03-03 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-11 Deutsche Bank Initiate Buy
2025-02-10 Needham Reiterate Buy -> Buy
2025-01-21 Truist Securities Maintains Buy -> Buy
2024-12-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-07 Needham Reiterate Buy -> Buy
2024-11-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-31 Oppenheimer Maintains Outperform -> Outperform
2024-09-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-05 Needham Reiterate Buy -> Buy
2024-09-04 Needham Maintains Buy -> Buy
2024-09-04 Oppenheimer Reiterate Outperform -> Outperform
2024-09-03 Needham Reiterate Buy -> Buy
2024-09-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-15 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-14 Guggenheim Maintains Buy -> Buy
2024-08-14 Needham Reiterate Buy -> Buy
2024-08-14 Oppenheimer Reiterate Outperform -> Outperform
2024-08-14 Wedbush Maintains Neutral -> Neutral
2024-08-12 Needham Reiterate Buy -> Buy
2024-08-05 Oppenheimer Initiate Outperform
2024-07-01 Piper Sandler Maintains Overweight -> Overweight